NYSE - Delayed Quote • USD
Ginkgo Bioworks Holdings, Inc. (DNA)
At close: May 17 at 4:00 PM EDT
After hours: May 17 at 7:59 PM EDT
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Jason Kelly | Founder, CEO & Director | 262.5k | -- | 1981 |
| Dr. Reshma P. Shetty | Founder, President, COO & Director | 262.5k | -- | 1981 |
| Mr. Mark E. Dmytruk | Chief Financial Officer | 476.5k | -- | 1972 |
| Mr. Thomas Knight Jr. | Founder | -- | -- | -- |
| Mr. Austin Che Ph.D. | Founder, Head of Strategy & Treasurer | -- | -- | -- |
| Mr. Bartholomew Canton | Founder, CTO & Secretary | -- | -- | -- |
| Mr. Steven P. Coen CPA | Chief Accounting Officer | -- | -- | -- |
| Karen Tepichin | General Counsel & Secretary | -- | -- | -- |
| Ms. Anna Marie Wagner | Senior Vice President of Corporate Development | -- | -- | -- |
| Ms. Samantha Sutton | Head of People | -- | -- | -- |
Ginkgo Bioworks Holdings, Inc.
27 Drydock Avenue
8th Floor
Boston, MA 02210
United States
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 1,218
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Corporate Governance
Ginkgo Bioworks Holdings, Inc.’s ISS Governance QualityScore as of May 1, 2024 is 10. The pillar scores are Audit: 9; Board: 6; Shareholder Rights: 10; Compensation: 9.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
March 1, 2024 at 9:01 PM UTC - March 5, 2024 at 9:01 PM UTC
Ginkgo Bioworks Holdings, Inc. Earnings Date
Recent Events
Related Tickers
RXRX Recursion Pharmaceuticals, Inc.
9.42
-0.95%
CRSP CRISPR Therapeutics AG
56.22
+0.99%
NTLA Intellia Therapeutics, Inc.
26.22
+0.19%
BEAM Beam Therapeutics Inc.
24.62
+3.49%
JAGX Jaguar Health, Inc.
0.2585
-9.84%
BLUE bluebird bio, Inc.
1.0300
-1.90%
EDIT Editas Medicine, Inc.
5.62
-4.58%
IOVA Iovance Biotherapeutics, Inc.
10.24
-1.82%
NVAX Novavax, Inc.
13.01
-9.65%
IBRX ImmunityBio, Inc.
7.65
-1.29%